Leading generics pharmaceutical company
Current Events
There is a question about what role race and wealth play in how much attention and funding the disease receives. Sickle cell disease affects about 100,000 Americans, most of them African-Americans. There are few treatments for it, and experts say not enough is being done to prevent complications. Just recently, the Centers for Medicare […]
Latest Mediscor review says generic utilisation rate more than doubled from 27.7% in 2002 to 62.4% in 2018 The use of cheaper generic alternatives that are no longer patent-protected rose to an all-time high in the private sector in 2018, according to the latest Mediscor review. The trend highlights the continued impact of the […]
As per the study conducted by Journal of Drug Delivery and Therapeutics, about 62% of healthcare providers want to substitute generic drugs but not for all the cases they treat, thus indicates the perception of the efficacy of the two classes of medicines. With the escalating cost of healthcare facilities, many people in India […]
India has decided to rethink which medicines can and can’t be sold without prescriptions. These measures will finally create a definition for over the counter (OTC) drugs and possibly curb the sale of some dangerous medicines. So what separates OTC drugs from prescription-only and why is this categorisation so important? In November 2016, India’s drug […]
Date: March 5, 2019 In a move to promote low-cost generic medicines, the government plans to color code such drugs to enable consumers to differentiate between generic medicines and other drugs and take an informed decision while purchasing them from chemists. Apart from color coding, the government is also considering use of symbols to […]
Medicare could have saved nearly 90% of spending on angiotensin converting enzyme inhibitors and angiotensin-II-receptor blockers in 2016 and 2017 through generic substitute or therapeutic interchange, according to study results published in JAMA Internal Medicine. “Prescription drug spending accounts for an increasing share of U.S. health care costs.” Mathew E. Growdon, MD, MPH, of the […]
Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC. SPC’s are defined as IP rights extending patent protection for up to five years for medicines that are […]
It’s pretty much just two women who name the 200-plus drugs that come out every year Generic prescriptions allow patients to get the medicines they need at a lower price, without sacrificing the quality of treatment because, as we know, generic drugs are required by the FDA to be nearly identical to their name-brand […]
According to the World Health Organization, sham drugs are the world’s most lucrative counterfeit goods, with a global market worth roughly $200bn, and Africa accounts for around 42% of the world’s cases. But what is behind this scourge, and what can be done to stop it? Abi Miller finds out. Counterfeit drugs are a deadly, […]
A nationwide shortage of a generic drug that can shrink and control brain tumors in children raises questions about how critical medicines can go scarce. Life-saving pediatric cancer drugs are frequently unavailable due to shortages. Since being diagnosed with a brain tumor nearly a year ago, my son has lived much like any 5-year-old – in […]
